caa a22 4500 397593414 CHVBK 20180308164945.0 cr unu---uuuuu 161202e199608 xx s 000 0 eng 10.1093/jac/38.2.265 doi (NATIONALLICENCE)oxford-10.1093/jac/38.2.265 In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against Gram-positive clinical isolates from cancer patients [Elektronische Daten] [K. V. I. Rolston, N. Dholakia, D. H. Ho, B. LeBlanc, T. Dvorak, H. Streeter] The in-vitro activities of ramoplanin, vancomycin, and teicoplanin against Gram-positive organisms isolated from cancer patients were determined. Ramoplanin was the most active agent tested inhibiting all isolates at a concentration of ≤0.5 mg/L. Although all isolates were also susceptible to vancomycin and teicoplanin, their activities were surpassed by that of ramoplanin. The activity of teicoplanin was moderately better than that of vancomycin against Bacillus cereus, Enterococcus faecium, Listeria monocytogenes, methicillin-resistant Staphylococcus aureus, and most streptococcal isolates, and was comparable to vancomycin for the remainder of the isolates tested. © 1996 by the British Society for Antimicrobial Chemotherapy Brief reports nationallicence Rolston K. V. I. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut Dholakia N. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut Ho D. H. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut LeBlanc B. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut Dvorak T. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut Streeter H. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut Journal of Antimicrobial Chemotherapy Oxford University Press 38/2(1996-08), 265-269 0305-7453 38:2<265 1996 38 jac https://doi.org/10.1093/jac/38.2.265 text/html Onlinezugriff via DOI 1 brief-communication jats NATIONALLICENCE 856 40 https://doi.org/10.1093/jac/38.2.265 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Rolston K. V. I. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut NATIONALLICENCE 700 1- Dholakia N. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut NATIONALLICENCE 700 1- Ho D. H. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut NATIONALLICENCE 700 1- LeBlanc B. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut NATIONALLICENCE 700 1- Dvorak T. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut NATIONALLICENCE 700 1- Streeter H. Section of Infectious Diseases, Department of Medical Specialties, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA aut NATIONALLICENCE 773 0- Journal of Antimicrobial Chemotherapy Oxford University Press 38/2(1996-08), 265-269 0305-7453 38:2<265 1996 38 jac Metadata rights reserved CC BY-NC-4.0 http://creativecommons.org/licenses/by-nc/4.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-oxford